Emergence of Delafloxacin-Resistant Staphylococcus aureus in Brooklyn, New York

作者：Alejandro Iregui, Zeb Khan, Saquib Malik, David Landman, John M. Quale · 发表于：Clinical Infectious Diseases · 年份：2019 · DOI：10.1093/cid/ciz787 · 被引用次数：35 · 研究领域：Antimicrobial Resistance in Staphylococcus、Bacterial Identification and Susceptibility Testing、Streptococcal Infections and Treatments

Delafloxacin is an option for infections due to methicillin-resistant Staphylococcus aureus. In 2017, 22% of isolates from 7 hospitals in Brooklyn, New York, were nonsusceptible to delafloxacin. Isolates belonging to ST105, a strain associated with healthcare-related infections, predominated. Resistance was also found in ST8, a strain (USA300) associated with community-associated infections.